Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LENSAR Ends Merger Deal
AI Briefing
- GSK's Lynavoy receives FDA approval
- REPROXALAP rejected again by FDA
- LENSAR ends merger deal
Advertisement
← EU Feed BUSINESS